ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Return on Assets

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥545.1B
P/E ratio
15.1x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 20265.5-32.09%
Mar 31, 20258.1-15.67%
Mar 31, 20249.6+5.75%
Mar 31, 20239.1+7.10%
Mar 31, 20228.5+11.18%
Mar 31, 20217.6+2.70%
Mar 31, 20207.4+51.33%
Mar 31, 20194.9+0.20%
Mar 31, 20184.9-12.07%
Mar 31, 20175.6+8.82%
Mar 31, 20165.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat